Glycom A/S

Denmark

Back to Profile

1-100 of 251 for Glycom A/S Sort by
Query
Aggregations
IP Type
        Patent 236
        Trademark 15
Jurisdiction
        World 128
        United States 116
        Canada 5
        Europe 2
Date
2024 7
2023 16
2022 24
2021 30
2020 28
See more
IPC Class
A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages 116
C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages 64
C07H 1/06 - SeparationPurification 44
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins 44
C07H 1/00 - Processes for the preparation of sugar derivatives 35
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 15
01 - Chemical and biological materials for industrial, scientific and agricultural use 14
30 - Basic staples, tea, coffee, baked goods and confectionery 12
29 - Meat, dairy products, prepared or preserved foods 10
32 - Beers; non-alcoholic beverages 4
Status
Pending 33
Registered / In Force 218
  1     2     3        Next Page

1.

MIXTURE OF HMOs

      
Application Number 18808271
Status Pending
Filing Date 2024-08-19
First Publication Date 2024-12-12
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vignæs, Louise Kristine

Abstract

The invention relates to a mixture of human milk oligosaccharides that consists essentially of: LNnT, LNT, 2′-FL, 3′-SL, 6′-SL, either DFL or 3-FL, preferably DFL, useful for preventing and/or treating viral and/or bacterial infections in a non-infant human.

IPC Classes  ?

  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/12 - Fatty acids or derivatives thereof
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A23L 33/19 - Dairy proteins
  • A23L 33/195 - Proteins from microorganisms
  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 31/04 - Antibacterial agents
  • A61P 31/12 - Antivirals

2.

SEPARATION OF CHARGED OLIGOSACCHARIDES

      
Application Number 18257979
Status Pending
Filing Date 2021-12-17
First Publication Date 2024-04-18
Owner GLYCOM A/S (Denmark)
Inventor Matwiejuk, Martin

Abstract

The present invention concerns a method for separating different oligosaccharides having at least one carboxylic acid group by contacting them with basic anion exchange resins.

IPC Classes  ?

  • C07H 7/033 - Uronic acids
  • B01D 15/36 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
  • B01J 41/07 - Processes using organic exchangers in the weakly basic form
  • C07H 1/06 - SeparationPurification

3.

BIOMASS REMOVAL BY CENTRIFUGATION

      
Application Number 18257986
Status Pending
Filing Date 2021-12-17
First Publication Date 2024-03-28
Owner Glycom A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Wieser, Marco
  • Thøgersen, Jesper

Abstract

Disclosed herein are systems and methods for the purification of human milk oligosaccharides (HMOs). The HMOs can be purified from a suspension containing one or more of a bacterial biomass, cell fragments, small particles, and biomolecules. Advantageously, the solution can be pre-treated prior to centrifuging to form a clarified supernatant containing purified HMOs.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

4.

NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN PRODUCTION OF SIALYLATED HMOS

      
Application Number 18262099
Status Pending
Filing Date 2022-01-21
First Publication Date 2024-03-28
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • D'Arrigo, Isotta
  • Bych Kampmann, Katrine
  • Papadakis, Manos

Abstract

The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of sialylated human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS), the protein expressed being Fred.

IPC Classes  ?

  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
  • C07K 14/24 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
  • C12N 9/10 - Transferases (2.)
  • C12N 15/52 - Genes encoding for enzymes or proenzymes
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

5.

A DFL-PRODUCING STRAIN

      
Application Number 18258770
Status Pending
Filing Date 2021-12-21
First Publication Date 2024-02-08
Owner GLYCOM A/S (Denmark)
Inventor Pedersen, Margit

Abstract

The present invention relates to a genetically modified cell expressing an α-1,2-fucosyltransferase and an α-1,3-fucosyltransferase, and a transporter protein of the major facilitator superfamily (MFS) and to a method for recombinant production of human milk oligosaccharides (HMOs) using said genetically modified cell. More particularly, the invention provides a method for recombinant production of and a genetically modified cell capable of producing difucosyllactose (DFL) as the most abundant HMO, with a relatively low content of 3-fucosyllactose (3FL) and/or 2′-fucosyllactose (2′FL).

IPC Classes  ?

  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
  • C12N 9/10 - Transferases (2.)

6.

Purification of sialooligosaccharides

      
Application Number 18550209
Grant Number 12258603
Status In Force
Filing Date 2022-03-11
First Publication Date 2024-02-08
Grant Date 2025-03-25
Owner Glycom A/S (Denmark)
Inventor Molla, Getachew S.

Abstract

The present invention relates to the isolation and purification of sialylated oligosaccharides from an aqueous medium in which they are produced.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • C07H 1/08 - SeparationPurification from natural products
  • C12N 9/10 - Transferases (2.)
  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

7.

HUMAN MILK OLIGOSACCHARIDES FOR USE IN SUPPORTING MATURATION OR IMPROVEMENT OF SLEEPING PATTERNS

      
Application Number 18255703
Status Pending
Filing Date 2021-12-03
First Publication Date 2024-01-25
Owner GLYCOM A/S (Denmark)
Inventor
  • Admunsen, Ingvild Dybdrodt
  • Garcia-Rodenas, Clara Lucia
  • Hauser, Jonas

Abstract

The present invention relates to fucosylated human milk oligosaccharides for improving sleep maturation, for example improving trouble sleeping, in a non-infant.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61P 25/00 - Drugs for disorders of the nervous system

8.

COMPOSITION COMPRISING 2'-FL AND DFL FOR USE IN A METHOD FOR REDUCING PAIN

      
Application Number 17798270
Status Pending
Filing Date 2019-12-06
First Publication Date 2023-10-26
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Bergonzelli Degonda, Gabriela
  • Favre, Laurent
  • Ferrier, Laurent
  • Lucia, Clara

Abstract

The application relates to compositions containing 2′-FL and DFL for use in a method of reducing pain and/or the perception of visceral pain in a non-infant human.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate

9.

HMO PRODUCTION

      
Application Number 17759273
Status Pending
Filing Date 2021-01-22
First Publication Date 2023-07-20
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • Kampmann, Katrine Bych

Abstract

The present invention relates to the field of recombinant production of biological molecules in host cells. More particularly it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS).

IPC Classes  ?

  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C07K 14/24 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia

10.

HMO PRODUCTION

      
Application Number 17759270
Status Pending
Filing Date 2021-01-22
First Publication Date 2023-06-22
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • Papadakis, Manos
  • Kampmann, Katrine Bych

Abstract

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic encoding a putative transporter protein of the MFS superfamily; and methods using said cell for the production of oligosaccharide(s), preferably an HMO.

IPC Classes  ?

  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
  • C12N 9/10 - Transferases (2.)
  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C07K 14/24 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia

11.

METHODS FOR PROVIDING A SOLID HMO PRODUCT, AND SOLID HMO PRODUCTS OBTAINED THEREBY

      
Application Number 17906701
Status Pending
Filing Date 2021-01-29
First Publication Date 2023-05-04
Owner GLYCOM A/S (Denmark)
Inventor Chassagne, Pierre

Abstract

Various methods are provided for providing a solid HMO product, said methods including drum-drying, belt drying, preferably vacuum bed drying, or granulation. Solid HMO products are obtained via said methods, as well as solid HMO products per se. The methods can provide solid HMO products which are different to those achieved via other methods.

IPC Classes  ?

  • A23C 9/20 - Dietetic milk products not covered by groups
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
  • F26B 5/12 - Drying solid materials or objects by processes not involving the application of heat by suction
  • F26B 15/18 - Machines or apparatus for drying objects with progressive movementMachines or apparatus with progressive movement for drying batches of material in compact form with movement in a path composed of one or more straight lines, e.g. compound the lines being all horizontal or slightly inclined the objects or batches of materials being carried by endless belts
  • A23C 1/03 - Drying in thin layers on drums or rollers
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A23L 3/48 - Thin layer-, drum- or roller-drying
  • A23P 10/22 - Agglomeration or granulation with pulverisation of solid particles, e.g. in a free-falling curtain
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23C 9/146 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
  • A23C 9/142 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration

12.

SYNTHETIC COMPOSITION FOR TREATING METABOLIC DISORDERS

      
Application Number 18082793
Status Pending
Filing Date 2022-12-16
First Publication Date 2023-04-20
Owner GLYCOM A/S (Denmark)
Inventor
  • Elison, Emma
  • Mcconnell, Bruce
  • Hennet, Thierry
  • Vigsnæs, Louise Kristine

Abstract

A method for treating metabolic disorders includes determining a treatment group comprising obese non-infant humans; formulating a composition comprising one or more synthetic non-fucosylated human milk oligosaccharides (HMOs) selected from lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT) and/or 2′-fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), difucosyllactose (DFL), and lacto-N-fucopentaose I (LNFP-I), that are effective for: increasing in the gastrointestinal microbiota of a non-infant human during a treatment period, the relative abundance of Bifidobacterium adolescentis and reducing a precursor condition for a metabolic disorder associated with development of one or more of obesity-induced pre-diabetes and type 2 diabetes, the precursor condition selected from gut permeability, metabolic endotoxemia, low-grade metabolic inflammation, and body fat percentage; and reducing the precursor condition in at least one non-infant human in the treatment group by providing the composition to the at least one non-infant human during the treatment period.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
  • A61K 31/7004 - Monosaccharides having only carbon, hydrogen and oxygen atoms
  • A61K 9/00 - Medicinal preparations characterised by special physical form

13.

CRYSTALLIZATION OF 2'-FL

      
Application Number 17906131
Status Pending
Filing Date 2021-03-12
First Publication Date 2023-04-13
Owner Glycom A/S (Denmark)
Inventor
  • Molla, Getachew S.
  • Chassagne, Pierre

Abstract

The invention relates to a method for selective crystallization of 2′-FL from an aqueous solution comprising 2′-FL and one or more other fucosylated carbohydrates by adding acetic acid to the solution.

IPC Classes  ?

  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C07H 1/06 - SeparationPurification
  • C13B 30/02 - CrystallisationCrystallising apparatus

14.

NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN HMO PRODUCTION

      
Application Number 17759276
Status Pending
Filing Date 2021-01-22
First Publication Date 2023-04-13
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • D'Arrigo, Isotta
  • Kampmann, Katrine Bych
  • Papadakis, Manos

Abstract

The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS), the protein expressed being Fred.

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C12N 1/20 - BacteriaCulture media therefor

15.

HMO PRODUCTION

      
Application Number 17759275
Status Pending
Filing Date 2021-01-22
First Publication Date 2023-04-06
Owner GLYCOM A/S (Denmark)
Inventor Papadakis, Manos

Abstract

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using said cell for the production the oligosaccharide, preferably an HMO.

IPC Classes  ?

  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
  • C07K 14/24 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia

16.

Amorphous mixture comprising a neutral mono- or oligosaccharide and an acidic non-carbohydrate component

      
Application Number 18057355
Grant Number 11939351
Status In Force
Filing Date 2022-11-21
First Publication Date 2023-03-30
Grant Date 2024-03-26
Owner GLYCOM A/S (Denmark)
Inventor
  • Podányi, Benjámin
  • Chassagne, Pierre
  • Matwiejuk, Martin
  • Jondelius Hederos, Markus

Abstract

It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for improving the chemical stability and/or the physical features of an amorphous carbohydrate.

IPC Classes  ?

  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • C07H 3/02 - Monosaccharides

17.

Amorphous mixture comprising a neutral mono- or oligosaccharide and an acidic non-carbohydrate component

      
Application Number 18057360
Grant Number 12054513
Status In Force
Filing Date 2022-11-21
First Publication Date 2023-03-30
Grant Date 2024-08-06
Owner GLYCOM A/S (Denmark)
Inventor
  • Podányi, Benjámin
  • Chassagne, Pierre
  • Matwiejuk, Martin
  • Jondelius Hederos, Markus

Abstract

It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for improving the chemical stability and/or the physical features of an amorphous carbohydrate.

IPC Classes  ?

  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • C07H 3/02 - Monosaccharides

18.

HMO production

      
Application Number 17759261
Grant Number 12351806
Status In Force
Filing Date 2021-01-22
First Publication Date 2023-02-16
Grant Date 2025-07-08
Owner GLYCOM A/S (Denmark)
Inventor
  • Papadakis, Manos
  • Kampmann, Katrine Bych

Abstract

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using said cell for the production the oligosaccharide, preferably an HMO.

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C12N 5/10 - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells
  • C12N 15/74 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C12P 19/02 - Monosaccharides
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

19.

SEPARATION OF SIALYLATED OLIGOSACCHARIDES FROM FERMENTATION BROTH

      
Application Number 17757646
Status Pending
Filing Date 2020-12-18
First Publication Date 2023-02-02
Owner Glycom A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Molla, Getachew S.
  • Matwiejuk, Martin
  • Chassagne, Pierre

Abstract

The present invention relates to the separation and isolation of sialylated human milk oligosaccharides (HMOs) from the reaction mixture in which they are produced.

IPC Classes  ?

  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • B01D 61/58 - Multistep processes
  • B01D 69/02 - Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or propertiesManufacturing processes specially adapted therefor characterised by their properties
  • B01D 71/56 - Polyamides, e.g. polyester-amides
  • C12P 19/26 - Preparation of nitrogen-containing carbohydrates

20.

Mixture of HMOS for treating wheat sensitivity

      
Application Number 17934123
Grant Number 11986487
Status In Force
Filing Date 2022-09-21
First Publication Date 2023-01-19
Grant Date 2024-05-21
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in, and a method for the treatment of, secondary prevention of, and/or induction of tolerance to non-coeliac wheat and/or gluten sensitivity in a human.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

21.

MIXTURE OF HMOS FOR IMPROVING THE MICROBIOTA OF PREGNANT WOMEN

      
Application Number 17780390
Status Pending
Filing Date 2020-11-30
First Publication Date 2023-01-12
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Seitzberg, Dorthe
  • Amundsen, Ingvild Dybdrodt
  • Soyyilmaz, Buket

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in supplementing the diet of a pregnant woman, a synthetic composition comprising an HMO for use in supplementing the diet of a pregnant woman, and a method for improving health outcomes in an infant by supplementing the diet of a pregnant woman.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 17/00 - Drugs for dermatological disorders
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61P 37/00 - Drugs for immunological or allergic disorders
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof

22.

MIXTURE OF HMOs

      
Application Number 17780869
Status Pending
Filing Date 2020-11-27
First Publication Date 2023-01-05
Owner Glycom A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce
  • Seitzberg, Dorthe
  • Amundsen, Ingvild Dybdrodt

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in, and a method for prophylactically reducing gastrointestinal IBS symptom severity and/or symptom occurrence in a lac-tose-intolerant, IBS patient; reintroducing a source of lactose into the diet of a lactose-intolerant, IBS patient while prophylactically reducing gastrointestinal IBS symptom severity and/or symptom occurrence in the IBS patient; and/or reducing the severity and/or occurrence of non-gastrointestinal symptoms in a lactose-intolerant, IBS patient.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/12 - Antidiarrhoeals

23.

Mixture of HMOs

      
Application Number 17929905
Grant Number 12063949
Status In Force
Filing Date 2022-09-06
First Publication Date 2023-01-05
Grant Date 2024-08-20
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vignæs, Louise Kristine

Abstract

A synthetic mixture of human milk oligosaccharides (HMOs) consisting essentially of lacto-N-neotetraose (LNnT), lacto-N-tetraose (LNT), 2′-fucosyllactose (2′FL), 3′-O-sialyllactose (3′-SL), 6′-O-sialyllactose (6′-SL) either difucosyllactose (DFL) or 3-fucosyllactose (3-FL), preferably DFL, and optionally lactose. Said synthetic composition is useful for: treating or preventing viral and/or bacterial infection in a non-infant human; modulating the microbiota of a non-infant human; and/or improving the cognitive function of a non-infant human and as a pharmaceutical or nutritional composition.

IPC Classes  ?

  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 31/04 - Antibacterial agents
  • A61P 31/12 - Antivirals
  • A23L 33/12 - Fatty acids or derivatives thereof
  • A23L 33/19 - Dairy proteins
  • A23L 33/195 - Proteins from microorganisms

24.

COMPOSITIONS COMPRISING HMOS, THEIR PRODUCTION AND USE FOR THE PREVENTION AND/OR TREATMENT OF VIRAL AND/OR BACTERIAL INFECTIONS

      
Application Number 17821282
Status Pending
Filing Date 2022-08-22
First Publication Date 2022-12-15
Owner GLYCOM A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Jondelius Hederos, Markus
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

A mixture of human milk oligosaccharides that comprises or consists essentially of a) LNTri II, LNT, pLNH II and optionally lactose, or b) LNTri II, LNnT, pLNnH and optionally lactose, and is useful for preventing or treating viral or bacterial, intestinal and respiratory infections and for modulating the human gastrointestinal microbiota to increase Bifidobacterium abundance. A process for preparing the mixture and methods of crystallizing LNnT and LNT is also described.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
  • C12P 1/04 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymesGeneral processes for the preparation of compounds or compositions by using microorganisms or enzymes by using bacteria
  • C12N 9/10 - Transferases (2.)
  • A61K 31/716 - Glucans
  • A61P 31/04 - Antibacterial agents
  • A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
  • A61K 31/7032 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyl-diacylglycerides, lactobionic acid, gangliosides
  • C07H 1/00 - Processes for the preparation of sugar derivatives

25.

SYNTHETIC COMPOSITION FOR BALANCING THE BILE ACID PROFILE IN THE INTESTINE

      
Application Number 17755956
Status Pending
Filing Date 2020-11-13
First Publication Date 2022-12-01
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

This invention relates to a method and composition for balancing the bile acid profile in the intestine of humans, particularly decreasing primary bile acids and/or increasing production of secondary bile acids.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 35/745 - Bifidobacteria
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61P 1/12 - Antidiarrhoeals

26.

SEPARATION OF NEUTRAL OLIGOSACCHARIDES FROM FERMENTATION BROTH

      
Application Number 17754400
Status Pending
Filing Date 2020-10-01
First Publication Date 2022-10-27
Owner Glycom A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Chassagne, Pierre
  • Mathiesen, Flemming
  • Thøgersen, Jesper
  • Matwiejuk, Martin

Abstract

The present invention relates to the separation and isolation of neutral human milk oligosaccharides (HMOs) from the reaction mixture in which they are produced.

IPC Classes  ?

  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • B01D 61/16 - Feed pretreatment
  • B01D 61/58 - Multistep processes
  • B01J 39/05 - Processes using organic exchangers in the strongly acidic form

27.

PURIFICATION OF SIALOOLIGOSACCHARIDES

      
Application Number IB2022052207
Publication Number 2022/190055
Status In Force
Filing Date 2022-03-11
Publication Date 2022-09-15
Owner GLYCOM A/S (Denmark)
Inventor Molla, Getachew S.

Abstract

The present invention relates to the isolation and purification of sialylated oligosaccharides from an aqueous medium in which they are produced.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • B01D 15/36 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
  • C12P 19/26 - Preparation of nitrogen-containing carbohydrates

28.

SYNTHESIS OF THE FUCOSYLATED OLIGOSACCHARIDE LNFP-V

      
Application Number 17299583
Status Pending
Filing Date 2019-12-04
First Publication Date 2022-09-08
Owner GLYCOM A/S (Denmark)
Inventor
  • Papadakis, Manos
  • Pedersen, Margit

Abstract

The present invention provides a method for biotechnological production of LNFP-V by using recombinant bacterial cells. LNFP-V is produced by using a polypeptide having an a1,3/4-fucosyl transferase activity and comprising or consisting of an amino acid sequence that has a sequence identity of at least 90% with amino acid sequence of SEQ ID No. 1 or 3.

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12N 9/10 - Transferases (2.)
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

29.

NUCLEIC ACID CONSTRUCT COMPRISING 5' UTR STEM-LOOP FOR IN VITRO AND IN VIVO GENE EXPRESSION

      
Application Number 17596781
Status Pending
Filing Date 2020-06-19
First Publication Date 2022-08-25
Owner Glycom A/S (Denmark)
Inventor Pedersen, Margit

Abstract

The present invention relates to the field of recombinant production of biological molecules in host cells. The invention provides nucleic acid constructs that allow to modify expression of a desired gene using both in vitro and in vivo gene expression systems with optimized stem-loop structures in the 5′ UTR of said genes. The constructs can advantageously be used to produce a variety of biological molecules recombinantly in industrial scales, e.g. human milk oligosaccharides (HMOs)

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

30.

HUMAN MILK OLIGOSACCHARIDES AND COMPOSITIONS THEREOF FOR USE IN PREVENTING, MANAGING OR TREATING SYMPTOMS RELATED TO MIGRAINE

      
Application Number 17618366
Status Pending
Filing Date 2020-06-12
First Publication Date 2022-08-11
Owner Glycom A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in and a method for preventing, managing or treating postdrome symptoms of migraine, and/or abdominal migraine, and/or the secondary prevention of stress/anxiety induced migraine.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 35/20 - MilkWheyColostrum
  • A61P 1/14 - Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

31.

HUMAN MILK OLIGOSACCHARIDES FOR USE IN THE TREATMENT OF SYMPTOMS IN A PATIENT SUFFERING FROM NON-COELIAC WHEAT AND / OR GLUTEN SENSITIVITY

      
Application Number 17615479
Status Pending
Filing Date 2020-06-04
First Publication Date 2022-07-28
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in, and a method for prophylactically reducing symptom severity and/or occurrence in a non-coeliac wheat and/or gluten sensitivity patient, and for reducing the severity and/or occurrence of non-gastrointestinal symptoms in the patient.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

32.

COMPOSITION COMPRISING HMOs FOR PREVENTING OR REDUCING NOCICEPTION

      
Application Number 17723135
Status Pending
Filing Date 2022-04-18
First Publication Date 2022-07-28
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Damak, Sami
  • Sprenger, Norbert
  • Foata, Francis

Abstract

A method for reducing nociceptive sensitivity in non-infant humans includes in some examples selecting a non-infant human experiencing a condition and associated nociceptive sensitivity (e.g., irritable bowel syndrome or chronic neuropathic pain). In such examples, the method further includes selecting an effective amount of one or more human milk oligosaccharides (“HMOs”) chosen from the group consisting of 6′-sialyllactose (6′-SL), and a mixture of 6′-SL and lacto-N-tetraose (LNT) and reducing the nociceptive sensitivity by administering the selected effective amount of the chosen HMOs to the non-infant human during an initial phase. In some examples, the method includes activating GPR35 receptors by administering the effective amount of the chosen one or more HMOs. In some examples, the HMOs are a mixture of 6′-SL and LNT that provides a synergistic effect relative to each of the 6′-SL and LNT alone.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61K 31/7016 - Disaccharides, e.g. lactose, lactulose

33.

Oligosaccharide production

      
Application Number 17657787
Grant Number 11926858
Status In Force
Filing Date 2022-04-04
First Publication Date 2022-07-28
Grant Date 2024-03-12
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • Papadakis, Manos
  • Becker, Peter
  • Samain, Eric
  • Peltier-Pain, Pauline
  • Bych, Katrine
  • Johanson, Ted
  • Champion, Elise
  • Dekany, Gyula

Abstract

The invention relates to a genetically modified microorganism for making a oligosaccharide, preferably of 3-8 monosaccharide units, more preferably of 3-5 monosaccharide units, particularly a HMO, which comprises one or more genes encoding a sucrose utilization system, so the microorganism can use sucrose as a carbon and energy source.

IPC Classes  ?

  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
  • C07K 14/245 - Escherichia (G)
  • C12N 9/10 - Transferases (2.)
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
  • C12N 9/38 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase
  • C12N 15/52 - Genes encoding for enzymes or proenzymes
  • C12P 19/12 - Disaccharides

34.

NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN PRODUCTION OF SIALYLATED HMOS

      
Application Number EP2022051295
Publication Number 2022/157280
Status In Force
Filing Date 2022-01-21
Publication Date 2022-07-28
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • D'Arrigo, Isotta
  • Bych Kampmann, Katrine
  • Papadakis, Manos

Abstract

The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of sialylated human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS), the protein expressed being Fred.

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

35.

A DFL-PRODUCING STRAIN

      
Application Number EP2021086932
Publication Number 2022/136337
Status In Force
Filing Date 2021-12-21
Publication Date 2022-06-30
Owner GLYCOM A/S (Denmark)
Inventor Pedersen, Margit

Abstract

The present invention relates to a genetically modified cell expressing an α-1,2-fucosyltransferase and an α-1,3-fucosyltransferase, and a transporter protein of the major facilitator superfamily (MFS) and to a method for recombinant production of human milk oligosaccharides (HMOs) using said genetically modified cell. More particularly, the invention provides a method for recombinant production of and a genetically modified cell capable of producing difucosyllactose (DFL) as the most abundant HMO, with a relatively low content of 3-fucosyllactose (3FL) and/or 2'-fucosyllactose (2'FL).

IPC Classes  ?

36.

SEPARATION OF CHARGED OLIGOSACCHARIDES

      
Application Number IB2021061932
Publication Number 2022/130322
Status In Force
Filing Date 2021-12-17
Publication Date 2022-06-23
Owner GLYCOM A/S (Denmark)
Inventor Matwiejuk, Martin

Abstract

The present invention concerns a method for separating different oligosaccharides having at least one carboxylic acid group, also referred to as charged oligosaccharides. The method allows for the high throughput separation of oligosaccharides that are otherwise difficult to separate in non-chromatographic methods and involves the use of a weakly basic macroporous anion exchange resin.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • B01D 15/36 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
  • B01J 41/07 - Processes using organic exchangers in the weakly basic form
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

37.

BIOMASS REMOVAL BY CENTRIFUGATION

      
Application Number IB2021061934
Publication Number 2022/130324
Status In Force
Filing Date 2021-12-17
Publication Date 2022-06-23
Owner GLYCOM A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Wieser, Marco
  • Thøgersen, Jesper

Abstract

Disclosed herein are systems and methods for the purification of human milk oligosaccharides (HMOs). The HMOs can be purified from a suspension containing one or more of a bacterial biomass, cell fragments, small particles, and biomolecules. Advantageously, the solution can be pre-treated prior to centrifuging to form a clarified supernatant containing purified HMOs.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • B01D 21/26 - Separation of sediment aided by centrifugal force

38.

Crystalline forms of LNT

      
Application Number 17653819
Grant Number 11767340
Status In Force
Filing Date 2022-03-07
First Publication Date 2022-06-16
Grant Date 2023-09-26
Owner GLYCOM A/S (Denmark)
Inventor
  • Matwiejuk, Martin
  • Chassagne, Pierre
  • Jondelius Hederos, Markus

Abstract

The invention relates to crystalline polymorphs of lacto-N-tetraose (LNT) and methods for making the same for use in pharmaceutical compositions, nutritional formulations and food supplements.

IPC Classes  ?

  • C07H 13/04 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • C07H 1/06 - SeparationPurification

39.

HUMAN MILK OLIGOSACCHARIDES FOR USE IN SUPPORTING MATURATION OR IMPROVEMENT OF SLEEPING PATTERNS

      
Application Number IB2021061287
Publication Number 2022/118269
Status In Force
Filing Date 2021-12-03
Publication Date 2022-06-09
Owner GLYCOM A/S (Denmark)
Inventor
  • Admundsen, Ingvild Dybdrodt
  • Garcia-Rodenas, Clara Lucia
  • Hauser, Jonas

Abstract

The present invention relates to fucosylated human milk oligosaccharides for improving sleep maturation, for example improving trouble sleeping, in a non-infant.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A61P 25/00 - Drugs for disorders of the nervous system

40.

HUMAN MILK OLIGOSACCHARIDES FOR USE IN SUPPORTING NIGHT SLEEP DURATION

      
Application Number IB2021061288
Publication Number 2022/118270
Status In Force
Filing Date 2021-12-03
Publication Date 2022-06-09
Owner GLYCOM A/S (Denmark)
Inventor
  • Hauser, Jonas
  • Garcia-Rodenas, Clara Lucia
  • Lin, Weili
  • Cho, Seoyoon
  • Zhu, Ziliang
  • Li, Tengfei

Abstract

This invention relates to human milk oligosaccharides (HMOs) for use in a non-infants to support better sleep quality and improve night sleep duration.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

41.

HUMAN MILK OLIGOSACCHARIDES FOR USE IN ENHANCING EXECUTIVE FUNCTION

      
Application Number 17435944
Status Pending
Filing Date 2020-03-05
First Publication Date 2022-05-26
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Hauser, Jonas
  • Schneider, Nora

Abstract

Use of a human milk oligosaccharide (HMO), or a nutritional composition comprising a human milk oligosaccharide, to enhance executive function in a non-infant, to prevent and/or reduce the risk of sub-optimal executive function in a non-infant, to manage sub-optimal executive functioning in a non-infant, and/or to improve myelination to mature the pre-frontal cortex region of the brain in a non-infant, as well as synthetic compositions of HMOs and packs comprising at least 14 individual daily doses of an effective amount of at least one HMO for such a use.

IPC Classes  ?

  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

42.

Synthesis of oligosaccharides

      
Application Number 17646093
Grant Number 11919919
Status In Force
Filing Date 2021-12-27
First Publication Date 2022-04-21
Grant Date 2024-03-05
Owner GLYCOM A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Jondelius Hederos, Markus

Abstract

This invention relates to a method for the enzymatic synthesis of oligosaccharides, preferably human milk oligosaccharides (HMOs) The method comprises the enzymatic transfer of a glycosyl moiety and subsequent removal of by-products, such as lactose, by nanofiltration using a membrane comprising an active polyamide layer.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • A23L 3/00 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • B01D 61/02 - Reverse osmosisHyperfiltration
  • B01D 61/04 - Feed pretreatment
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • B01D 61/58 - Multistep processes
  • B01D 69/02 - Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or propertiesManufacturing processes specially adapted therefor characterised by their properties
  • B01D 69/12 - Composite membranesUltra-thin membranes
  • B01D 71/56 - Polyamides, e.g. polyester-amides
  • B01D 71/58 - Other polymers having nitrogen in the main chain, with or without oxygen or carbon only
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C08B 37/00 - Preparation of polysaccharides not provided for in groups Derivatives thereof
  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
  • C12P 19/12 - Disaccharides
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

43.

AMORPHOUS SIALYLATED OLIGOSACCHARIDES

      
Application Number 17310039
Status Pending
Filing Date 2020-01-16
First Publication Date 2022-03-24
Owner GLYCOM A/S (Denmark)
Inventor
  • Podányi, Benjámin
  • Matwiejuk, Martin
  • Molnár-Gábor, Dóra

Abstract

It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for improving the chemical stability and/or the physical features of an amorphous carbohydrate.

IPC Classes  ?

  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C07H 1/00 - Processes for the preparation of sugar derivatives

44.

Composition and method for treating humans using low-fodmap diets

      
Application Number 17417029
Grant Number 12233079
Status In Force
Filing Date 2019-12-19
First Publication Date 2022-03-10
Grant Date 2025-02-25
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine

Abstract

A synthetic composition and method for use in providing a source of oligosaccharides to a human consuming a low-FODMAP diet, increasing the abundance of bifidobacteria in the colon of a human consuming a low-FODMAP diet, and/or reintroducing FODMAPs into the diet of a human consuming a low-FODMAP diet. The composition contains one or more human milk oligosaccharides.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 35/20 - MilkWheyColostrum
  • A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 47/42 - ProteinsPolypeptidesDegradation products thereofDerivatives thereof, e.g. albumin, gelatin or zein
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61P 1/14 - Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

45.

SEPARATION OF OLIGOSACCHARIDES

      
Application Number 17415274
Status Pending
Filing Date 2019-12-19
First Publication Date 2022-02-24
Owner Glycom A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Jondelius Hederos, Markus
  • Chassagne, Pierre

Abstract

The invention relates to a method for the separation of two hydrophilic neutral oligosaccharides from each other with a chromatography on a bromine functionalized polystyrene cross-linked with divinylbenzene (BPS-DVB) stationary medium.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • C12P 19/26 - Preparation of nitrogen-containing carbohydrates
  • B01D 15/12 - Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed

46.

COMPOSITION AND METHOD FOR PROMOTING INTESTINAL BARRIER HEALING

      
Application Number 17417049
Status Pending
Filing Date 2019-12-19
First Publication Date 2022-02-24
Owner Glycom A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce
  • Damak, Sami
  • Foata, Francis
  • Sprenger, Norbert

Abstract

A composition and associated packs and methods for (i) promoting gastrointestinal barrier healing in the upper intestinal tract and/or small intestine of a non-infant human suffering from chronic intestinal barrier inflammation, and/or (ii) maintaining remission in the upper intestinal tract and small intestine of a non-infant human suffering from chronic intestinal barrier inflammation. The composition contains an effective amount of a combination of 6′-sialyllactose (6′-SL) and lacto-N-tetraose (LNT).

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 9/00 - Medicinal preparations characterised by special physical form

47.

OLIGOSACCHARIDE PRODUCTION

      
Application Number EP2021069310
Publication Number 2022/013143
Status In Force
Filing Date 2021-07-12
Publication Date 2022-01-20
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • Papadakis, Manos
  • Becker, Peter
  • Samain, Eric
  • Peltier-Pain, Pauline
  • Kampmann, Katrine Bych
  • Johanson, Ted
  • Champion, Elise
  • Dekany, Gyula

Abstract

The invention relates to a genetically modified microorganism for making an oligosaccharide, preferably of 3-8 monosaccharide units, more preferably of 3-5 monosaccharide units, particularly a HMO, which comprises one or more genes encoding a sucrose utilization system, so the microorganism can use sucrose as a carbon and energy source.

IPC Classes  ?

  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
  • C12P 19/12 - Disaccharides
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
  • C12P 19/26 - Preparation of nitrogen-containing carbohydrates
  • C07K 14/255 - Salmonella (G)
  • C07K 14/26 - Klebsiella (G)
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
  • C12N 15/52 - Genes encoding for enzymes or proenzymes

48.

Composition comprising HMSs/HMOs and use thereof

      
Application Number 17353749
Grant Number 11896605
Status In Force
Filing Date 2021-06-21
First Publication Date 2021-12-16
Grant Date 2024-02-13
Owner Glycom A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce
  • Elison, Emma

Abstract

This disclosure relates generally to compositions and methods for preventing or treating mast cell mediated visceral pain.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61K 31/7016 - Disaccharides, e.g. lactose, lactulose

49.

Synthetic composition and method for treating irritable bowel syndrome

      
Application Number 17341039
Grant Number 11833165
Status In Force
Filing Date 2021-06-07
First Publication Date 2021-10-07
Grant Date 2023-12-05
Owner GLYCOM A/S (Denmark)
Inventor
  • Hennet, Thierry
  • Mcconnell, Bruce
  • Elison, Emma
  • Vigsnæs, Louise Kristine

Abstract

The application relates to a method for treating a patient with irritable bowel syndrome (IBS), the method comprising administering to the patient one or more neutral human milk oligosaccharides (HMOs) selected from 2′-fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), difucosyllactose (DFL), lacto-N-fucopentaose I, lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), and combinations thereof.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 31/7004 - Monosaccharides having only carbon, hydrogen and oxygen atoms
  • A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
  • A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
  • A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
  • A23C 9/20 - Dietetic milk products not covered by groups

50.

Composition comprising HMSs/HMOs and use thereof

      
Application Number 17353730
Grant Number 11896604
Status In Force
Filing Date 2021-06-21
First Publication Date 2021-10-07
Grant Date 2024-02-13
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Elison, Emma
  • Vigsnæs, Louise Kristine

Abstract

The application relates to a method for the prophylaxis or treatment of non-infectious diarrhea in a human, the method comprising administering to the human an effective amount of one or more human milk oligosaccharides.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
  • A61P 1/12 - Antidiarrhoeals

51.

METHODS FOR PROVIDING A SOLID HMO PRODUCT, AND SOLID HMO PRODUCTS OBTAINED THEREBY

      
Application Number IB2021050703
Publication Number 2021/186258
Status In Force
Filing Date 2021-01-29
Publication Date 2021-09-23
Owner GLYCOM A/S (Denmark)
Inventor Chassagne, Pierre

Abstract

Various methods are provided for providing a solid HMO product, said methods including drum-drying, belt drying, preferably vacuum bed drying, or granulation. Solid HMO products are obtained via said methods, as well as solid HMO products per se. The methods can provide solid HMO products which are different to those achieved via other methods.

IPC Classes  ?

  • F26B 3/20 - Drying solid materials or objects by processes involving the application of heat by conduction, i.e. the heat is conveyed from the heat source, e.g. gas flame, to the materials or objects to be dried by direct contact the heat source being a heated surface
  • A23C 9/20 - Dietetic milk products not covered by groups
  • C07H 1/06 - SeparationPurification
  • F26B 3/24 - Drying solid materials or objects by processes involving the application of heat by conduction, i.e. the heat is conveyed from the heat source, e.g. gas flame, to the materials or objects to be dried by direct contact the heat source and the materials or objects to be dried being in relative motion, e.g. of vibration the movement being rotation
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

52.

CRYSTALLIZATION OF 2'-FL

      
Application Number IB2021052073
Publication Number 2021/181349
Status In Force
Filing Date 2021-03-12
Publication Date 2021-09-16
Owner GLYCOM A/S (Denmark)
Inventor
  • Molla, Getachew S.
  • Chassagne, Pierre

Abstract

The invention relates to a method for selective crystallization of 2'-FL from an aqueous solution comprising 2'-FL and one or more other fucosylated carbohydrates by adding acetic acid to the solution.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

53.

Synthetic composition for microbiota modulation

      
Application Number 17114850
Grant Number 11529365
Status In Force
Filing Date 2020-12-08
First Publication Date 2021-08-19
Grant Date 2022-12-20
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine

Abstract

A method and composition including an effective amount of one or more synthetic neutral HMOs are disclosed for modulating the microbiota in the gastro-intestinal tracts of non-infant humans who are carriers of the human fucosyltransferase 2 (FUT2) genetic mutation and for improving one or more gastrointestinal conditions.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
  • A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
  • A61K 35/20 - MilkWheyColostrum
  • A61K 35/00 - Medicinal preparations containing materials or reaction products thereof with undetermined constitution

54.

HMO PRODUCTION

      
Application Number EP2021051466
Publication Number 2021/148610
Status In Force
Filing Date 2021-01-22
Publication Date 2021-07-29
Owner GLYCOM A/S (Denmark)
Inventor Papadakis, Manos

Abstract

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using said cell for the production the oligosaccharide, preferably an HMO.

IPC Classes  ?

  • C07K 14/24 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

55.

HMO PRODUCTION

      
Application Number EP2021051468
Publication Number 2021/148611
Status In Force
Filing Date 2021-01-22
Publication Date 2021-07-29
Owner GLYCOM A/S (Denmark)
Inventor
  • Papadakis, Manos
  • Kampmann, Katrine, Bych

Abstract

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using said cell for the production the oligosaccharide, preferably an HMO.

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

56.

HMO PRODUCTION

      
Application Number EP2021051473
Publication Number 2021/148615
Status In Force
Filing Date 2021-01-22
Publication Date 2021-07-29
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • Papadakis, Manos
  • Kampmann, Katrine, Bych

Abstract

The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic encoding a putative transporter protein of the MFS superfamily; and methods using said cell for the production of oligosaccharide(s), preferably an HMO.

IPC Classes  ?

  • C07K 14/24 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

57.

NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (BAD) IN HMO PRODUCTION

      
Application Number EP2021051476
Publication Number 2021/148618
Status In Force
Filing Date 2021-01-22
Publication Date 2021-07-29
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • D'Arrigo, Isotta
  • Kampmann, Katrine, Bych
  • Papadakis, Manos

Abstract

The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS), the protein expressed being Bad.

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

58.

HMO PRODUCTION

      
Application Number EP2021051472
Publication Number 2021/148614
Status In Force
Filing Date 2021-01-22
Publication Date 2021-07-29
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • Kampmann, Katrine, Bych

Abstract

The present invention relates to the field of recombinant production of biological molecules in host cells. More particularly it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS).

IPC Classes  ?

  • C07K 14/195 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria
  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

59.

NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN HMO PRODUCTION

      
Application Number EP2021051479
Publication Number 2021/148620
Status In Force
Filing Date 2021-01-22
Publication Date 2021-07-29
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • D'Arrigo, Isotta
  • Kampmann, Katrine, Bych
  • Papadakis, Manos

Abstract

The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS), the protein expressed being Fred.

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

60.

Mixture of HMOs for treating autoimmune diseases

      
Application Number 17059942
Grant Number 11554131
Status In Force
Filing Date 2019-05-31
First Publication Date 2021-07-15
Grant Date 2023-01-17
Owner Glycom A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce
  • Rothaus Christensen, Kristine

Abstract

The invention relates to a method, compounds and compositions for the secondary prevention, treatment or dietary management of symptomatic and asymptomatic non-intestinal autoimmune diseases in a non-infant human including Sjogren's syndrome and type 1 diabetes. Said method, compounds and compositions for the secondary prevention, treatment or dietary management include human milk oligosaccharide (HMO), preferably mixtures of human milk oligosaccharides selected from the group of 2′-FL, LNnT, LNT, DFL, and 6′-SL.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 37/02 - Immunomodulators

61.

Synthetic composition for treating metabolic disorders

      
Application Number 17141772
Grant Number 11890293
Status In Force
Filing Date 2021-01-05
First Publication Date 2021-07-01
Grant Date 2024-02-06
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Elison, Emma

Abstract

Bifidobacterium adolescentis in the non-infant patient by administering the selected effective amount of the selected one or more HMOs and improving in the non-infant patient at least one condition selected from increased insulin sensitivity, reduced insulin resistance, improved gut barrier function, and reduction of metabolic inflammation. In various examples, the method includes increasing levels of at least one glucagon-like peptide.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/20 - Pills, lozenges or tablets

62.

SEPARATION OF SIALYLATED OLIGOSACCHARIDES FROM FERMENTATION BROTH

      
Application Number IB2020062166
Publication Number 2021/124234
Status In Force
Filing Date 2020-12-18
Publication Date 2021-06-24
Owner GLYCOM A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Molla, Getachew S.
  • Matwiejuk, Martin
  • Chassagne, Pierre

Abstract

The present invention relates to the separation and isolation of sialylated human milk oligosaccharides (HMOs) from the reaction mixture in which they are produced.

IPC Classes  ?

  • C12P 19/26 - Preparation of nitrogen-containing carbohydrates
  • C07H 1/06 - SeparationPurification
  • C07H 5/04 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
  • B01D 61/16 - Feed pretreatment
  • B01D 61/02 - Reverse osmosisHyperfiltration

63.

Mixture of HMOs for treating wheat sensitivity

      
Application Number 16768333
Grant Number 11452736
Status In Force
Filing Date 2018-11-30
First Publication Date 2021-06-10
Grant Date 2022-09-27
Owner GLYCOM A/S (USA)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in, and a method for the treatment of, secondary prevention of, and/or induction of tolerance to non-coeliac wheat and/or gluten sensitivity in a human.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

64.

COMPOSITION COMPRISING 2'-FL AND DFL FOR USE IN A METHOD FOR REDUCING PAIN

      
Application Number IB2020061578
Publication Number 2021/111422
Status In Force
Filing Date 2020-12-07
Publication Date 2021-06-10
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Bergonzelli Degonda, Gabriela
  • Favre, Laurent
  • Ferrier, Laurent
  • Garcia-Rodenas, Clara Lucia

Abstract

The application relates to compositions containing 2'-FL and DFL for use in a method of reducing pain and/or the perception of visceral pain in a non-infant human.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

65.

MIXTURE OF HMOs

      
Application Number IB2020061215
Publication Number 2021/105943
Status In Force
Filing Date 2020-11-27
Publication Date 2021-06-03
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce
  • Seitzberg, Dorthe
  • Amundsen, Ingvild Dybdrodt

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in, and a method for prophylactically reducing gastrointestinal IBS symptom severity and/or symptom occurrence in a lactose-intolerant, IBS patient; reintroducing a source of lactose into the diet of a lactose-intolerant, IBS patient while prophylactically reducing gastrointestinal IBS symptom severity and/or symptom occurrence in the IBS patient; and/or reducing the severity and/or occurrence of non-gastrointestinal symptoms in a lactose- intolerant, IBS patient.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 2/00 -
  • A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
  • A61P 25/00 - Drugs for disorders of the nervous system

66.

MIXTURE OF HMOS

      
Document Number 03161861
Status Pending
Filing Date 2020-11-27
Open to Public Date 2021-06-03
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnas, Louise Kristine
  • Mcconnell, Bruce
  • Seitzberg, Dorthe
  • Amundsen, Ingvild Dybdrodt

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in, and a method for prophylactically reducing gastrointestinal IBS symptom severity and/or symptom occurrence in a lactose-intolerant, IBS patient; reintroducing a source of lactose into the diet of a lactose-intolerant, IBS patient while prophylactically reducing gastrointestinal IBS symptom severity and/or symptom occurrence in the IBS patient; and/or reducing the severity and/or occurrence of non-gastrointestinal symptoms in a lactose- intolerant, IBS patient.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
  • A61P 25/00 - Drugs for disorders of the nervous system

67.

MIXTURE OF HMOS FOR IMPROVING THE MICROBIOTA OF PREGNANT WOMEN

      
Application Number IB2020061258
Publication Number 2021/105964
Status In Force
Filing Date 2020-11-30
Publication Date 2021-06-03
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Seitzberg, Dorthe
  • Amundsen, Ingvild Dybdrodt
  • Soyyilmaz, Buket

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in supplementing the diet of a pregnant woman, a synthetic composition comprising an HMO for use in supplementing the diet of a pregnant woman, and a method for improving health outcomes in an infant by supplementing the diet of a pregnant woman.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 31/125 - CamphorNuclear substituted derivatives thereof
  • A61P 1/06 - Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
  • A61P 25/00 - Drugs for disorders of the nervous system
  • A61P 37/00 - Drugs for immunological or allergic disorders

68.

SYNTHETIC COMPOSITION FOR BALANCING THE BILE ACID PROFILE IN THE INTESTINE

      
Document Number 03160629
Status Pending
Filing Date 2020-11-13
Open to Public Date 2021-05-20
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

This invention relates to a method and composition for balancing the bile acid profile in the intestine of humans, particularly decreasing primary bile acids and/or increasing production of secondary bile acids.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61P 1/10 - Laxatives
  • A61P 1/12 - Antidiarrhoeals
  • A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
  • A61P 3/04 - AnorexiantsAntiobesity agents
  • A61P 3/08 - Drugs for disorders of the metabolism for glucose homeostasis

69.

SYNTHETIC COMPOSITION FOR BALANCING THE BILE ACID PROFILE IN THE INTESTINE

      
Application Number IB2020060692
Publication Number 2021/094993
Status In Force
Filing Date 2020-11-13
Publication Date 2021-05-20
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

This invention relates to a method and composition for balancing the bile acid profile in the intestine of humans, particularly decreasing primary bile acids and/or increasing production of secondary bile acids.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61P 1/10 - Laxatives
  • A61P 1/12 - Antidiarrhoeals
  • A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
  • A61P 3/04 - AnorexiantsAntiobesity agents
  • A61P 3/08 - Drugs for disorders of the metabolism for glucose homeostasis

70.

Synthetic composition for treating antibiotic associated complications

      
Application Number 17120881
Grant Number 11998558
Status In Force
Filing Date 2020-12-14
First Publication Date 2021-04-08
Grant Date 2024-06-04
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Kronlage, David Paul

Abstract

The invention relates to a synthetic composition comprising human milk oligosaccharides for use in at least partially restoring the commensal gastrointestinal microbiota and preventing or mitigating antibiotic associated diarrhoea.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A61P 31/04 - Antibacterial agents

71.

Nucleic acid construct for in vitro and in vivo gene expression

      
Application Number 16956092
Grant Number 11608504
Status In Force
Filing Date 2018-12-19
First Publication Date 2021-04-08
Grant Date 2023-03-21
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • Papadakis, Manos

Abstract

The present invention relates to the field of recombining production of biological molecules in host cells. The invention provides nucleic acid constructs that allow to modify expression of a desired gene using both in vitro and in vivo gene expression systems. The constructs can advantageously be used to produce a variety of biological molecules recombinantly in industrial scales, e.g. human milk oligosaccharides (HMO).

IPC Classes  ?

  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/11 - DNA or RNA fragmentsModified forms thereof
  • C12N 15/67 - General methods for enhancing the expression

72.

SEPARATION OF NEUTRAL OLIGOSACCHARIDES FROM FERMENTATION BROTH

      
Application Number IB2020059201
Publication Number 2021/064629
Status In Force
Filing Date 2020-10-01
Publication Date 2021-04-08
Owner GLYCOM A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Chassagne, Pierre
  • Mathiesen, Flemming
  • Thøgersen, Jesper
  • Matwiejuk, Martin

Abstract

The present invention relates to the separation and isolation of neutral human milk oligosaccharides (HMOs) from the reaction milieu in which they are produced, preferably from a fermentation broth, comprising the steps of: i) optionally, centrifugation, microfiltration of the reaction milieu, or filtration of the reaction milieu on a filter press or a drum filter to obtain a pre-treated reaction milieu, ii) setting the pH of the pre-treated reaction milieu from step i) or the reaction milieu directly to 3-6 and optionally warming up the pre-treated reaction milieu from step i) or the reaction milieu directly to 35-65 [deg]C, and iii) contacting the reaction milieu obtained in step ii) to an ultrafiltration (UF) membrane with a molecular weight cut-off (MWCO) of 5-1000 kDa and collecting the permeate with the proviso that when step i) is not carried out, then the UF membrane is a non-polymeric membrane.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • B01D 61/16 - Feed pretreatment
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • B01D 61/04 - Feed pretreatment
  • B01J 39/05 - Processes using organic exchangers in the strongly acidic form

73.

Synthetic composition and method for modulating brain function and behaviour

      
Application Number 17099306
Grant Number 11684630
Status In Force
Filing Date 2020-11-16
First Publication Date 2021-03-18
Grant Date 2023-06-27
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Elison, Emma
  • Vigsnæs, Louise Kristine

Abstract

A synthetic composition for use in improving one or more co-morbid mental disorder symptoms of a patient with IBS, characterised in that the composition contains an effective amount of one or more neutral human milk oligosaccharides, is disclosed.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 25/22 - Anxiolytics
  • A61P 25/24 - Antidepressants
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/15 - Vitamins

74.

Synthetic composition for treating metabolic disorders

      
Application Number 17093337
Grant Number 11529364
Status In Force
Filing Date 2020-11-09
First Publication Date 2021-02-25
Grant Date 2022-12-20
Owner Glycom A/S (Denmark)
Inventor
  • Elison, Emma
  • Mcconnell, Bruce
  • Hennet, Thierry
  • Vigsnæs, Louise Kristine

Abstract

Bifidobacterium adolescentis and reducing in the non-infant human during the treatment period, a precursor condition for a metabolic disorder associated with development of one or more of obesity-induced pre-diabetes and type 2 diabetes, the precursor condition selected from gut permeability, metabolic endotoxemia, low-grade metabolic inflammation, and body fat percentage.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
  • A61K 31/7004 - Monosaccharides having only carbon, hydrogen and oxygen atoms
  • A61K 9/00 - Medicinal preparations characterised by special physical form

75.

Composition comprising HMOs for preventing or reducing nociception

      
Application Number 16956511
Grant Number 11304966
Status In Force
Filing Date 2018-12-19
First Publication Date 2021-01-14
Grant Date 2022-04-19
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Damak, Sami
  • Sprenger, Norbert
  • Foata, Francis

Abstract

The application relates to synthetic compositions and methods for preventing or reducing nociception and/or nociceptive sensitivity in a non-infant human. The human is administered a composition comprising 6′-sialyllactose (6′-SL) and/or lacto-N-tetraose (LNT).

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61K 31/7016 - Disaccharides, e.g. lactose, lactulose

76.

Synthetic composition and method for modulating emotion and mood disorders

      
Application Number 17026616
Grant Number 11491171
Status In Force
Filing Date 2020-09-21
First Publication Date 2021-01-07
Grant Date 2022-11-08
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Elison, Emma
  • Vigsnæs, Louise Kristine

Abstract

A synthetic composition for use in treating or improving one or more emotion and/or mood disorders in a patient, characterised in that the composition contains an effective amount of one or more neutral human milk oligosaccharides, is disclosed.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/15 - Vitamins
  • A61P 25/22 - Anxiolytics
  • A61P 25/24 - Antidepressants

77.

Synthetic composition for microbiota modulation

      
Application Number 17001118
Grant Number 11696921
Status In Force
Filing Date 2020-08-24
First Publication Date 2021-01-07
Grant Date 2023-07-11
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

B. pseudocatenulatum; for treating or preventing in said non-infant human with type 2 diabetes and/or obesity; an enteropathogenic infection; impaired gut barrier function and/or; an inflammation related to gastro¬intestinal condition, preferably irritable bowel disease (IBD) or irritable bowel syndrome (IBS); as a nutritional composition. The HMO is a fucosylated neutral HMO, a non-fucosylated neutral HMO, or a mixture of a fucosylated and a non-fucosylated neutral HMO. The HMOs comprises 2′-fucosyllactose (preferred), 2′-fucosyllactose (preferred), 3-fucosyllactose, difucosyllactose (preferred), lacto-N-fucopentaose, fucosyl-lacto-N-hexaose, fucosyl-para-lacto-N-hexaose, lacto-N-tetraose (preferred), lacto-N-neotetraose (preferred), lacto-N-hexaose, lacto-N-neohexaose, para-lacto-N-hexaose and para-lacto-N-neohexaose.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 3/04 - AnorexiantsAntiobesity agents
  • A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61K 9/00 - Medicinal preparations characterised by special physical form

78.

NUCLEIC ACID CONSTRUCT COMPRISING 5' UTR STEM-LOOP FOR IN VITRO AND IN VIVO GENE EXPRESSION

      
Application Number IB2020055773
Publication Number 2020/255054
Status In Force
Filing Date 2020-06-19
Publication Date 2020-12-24
Owner GLYCOM A/S (Denmark)
Inventor Pedersen, Margit

Abstract

The present invention relates to the field of recombinant production of biological molecules in host cells. The invention provides nucleic acid constructs that allow to modify expression of a desired gene using both in vitro and in vivo gene expression systems with optimized stem-loop structures in the 5' UTR of said genes. The constructs can advantageously be used to produce a variety of biological molecules recombinantly in industrial scales, e.g. human milk oligosaccharides (HMOs)

IPC Classes  ?

  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli

79.

HUMAN MILK OLIGOSACCHARIDES AND COMPOSITIONS THEREOF FOR USE IN PREVENTING, MANAGING OR TREATING SYMPTOMS RELATED TO MIGRAINE

      
Application Number IB2020055517
Publication Number 2020/250185
Status In Force
Filing Date 2020-06-12
Publication Date 2020-12-17
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in and a method for preventing, managing or treating postdrome symptoms of migraine, and/or abdominal migraine, and/or the secondary prevention of stress/anxiety induced migraine.

IPC Classes  ?

80.

HUMAN MILK OLIGOSACCHARIDES FOR USE IN THE TREATMENT OF SYMPTOMS IN A PATIENT SUFFERING FROM NON-COELIAC WHEAT AND/OR GLUTEN SENSITIVITY

      
Application Number IB2020055265
Publication Number 2020/245757
Status In Force
Filing Date 2020-06-04
Publication Date 2020-12-10
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in, and a method for prophylactically reducing symptom severity and/or occurrence in a non-coeliac wheat and/or gluten sensitivity patient, and for reducing the severity and/or occurrence of non-gastrointestinal symptoms in the patient.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 1/00 -

81.

Human milk oligosaccharides for treating migraine

      
Application Number 16770336
Grant Number 11602545
Status In Force
Filing Date 2018-11-30
First Publication Date 2020-11-12
Grant Date 2023-03-14
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in and a method for preventing or treating migraine in a human.

IPC Classes  ?

  • A61P 25/06 - Antimigraine agents
  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61K 35/20 - MilkWheyColostrum

82.

Oligosaccharide production

      
Application Number 16927700
Grant Number 11293042
Status In Force
Filing Date 2020-07-13
First Publication Date 2020-11-12
Grant Date 2022-04-05
Owner GLYCOM A/S (Denmark)
Inventor
  • Pedersen, Margit
  • Papadakis, Manos
  • Becker, Peter
  • Samain, Eric
  • Peltier-Pain, Pauline
  • Bych, Katrine
  • Johanson, Ted
  • Champion, Elise
  • Dekany, Gyula

Abstract

The invention relates to a genetically modified microorganism for making a oligosaccharide, preferably of 3-8 monosaccharide units, more preferably of 3-5 monosaccharide units, particularly a HMO, which comprises one or more genes encoding a sucrose utilization system, so the microorganism can use sucrose as a carbon and energy source.

IPC Classes  ?

83.

One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration

      
Application Number 16761164
Grant Number 11541069
Status In Force
Filing Date 2017-11-02
First Publication Date 2020-10-29
Grant Date 2023-01-03
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Amundsen, Ingvild Dybdrodt

Abstract

The invention relates to a human milk oligosaccharide (HMO) for use in reducing or preventing fatigue and/or improving focus or concentration on a mental or physical activity in a human. The invention also relates to a synthetic composition for use, comprising one or more of said HMOs. The invention further relates to a method for reducing or preventing fatigue and/or improving focus or concentration on a mental or physical activity by administering at least one HMO and the use of said one or more HMOs in a dietary management of a human.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

84.

Synthetic composition

      
Application Number 16303131
Grant Number 11224605
Status In Force
Filing Date 2017-05-19
First Publication Date 2020-10-22
Grant Date 2022-01-18
Owner Glycom A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce
  • Elison, Emma

Abstract

The application relates to synthetic compositions containing one or more human milk oligosaccharides for treating serotonin and/or tryptophan dysregulation.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61P 25/00 - Drugs for disorders of the nervous system

85.

Crystalline forms of LNT

      
Application Number 16913656
Grant Number 11267839
Status In Force
Filing Date 2020-06-26
First Publication Date 2020-10-15
Grant Date 2022-03-08
Owner GLYCOM A/S (Denmark)
Inventor
  • Matwiejuk, Martin
  • Chassagne, Pierre
  • Jondelius Hederos, Markus

Abstract

The invention relates to crystalline polymorphs of lacto-N-tetraose (LNT) and methods for making the same for use in pharmaceutical compositions, nutritional formulations and food supplements.

IPC Classes  ?

  • C07H 1/06 - SeparationPurification
  • C07H 13/04 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof

86.

HUMAN MILK OLIGOSACCHARIDES AND SYNTHETIC COMPOSITIONS THEREOF FOR MICROBIOTA MODULATION

      
Application Number 16768414
Status Pending
Filing Date 2018-11-30
First Publication Date 2020-10-15
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

The present invention relates to methods, compounds and compositions for modulating the microbiota in the gastro-intestinal tracts of humans, particularly for increasing the abundance of Akkermansia in the gut microbiota of humans.

IPC Classes  ?

  • A61K 35/20 - MilkWheyColostrum
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

87.

TERNARY MIXTURES OF 6'-SL, LNnT and LST c

      
Application Number 16913590
Status Pending
Filing Date 2020-06-26
First Publication Date 2020-10-08
Owner Glycom A/S (Denmark)
Inventor
  • Champion, Elise
  • Mcconnell, Bruce
  • Dekany, Gyula

Abstract

A mixture of human milk oligosaccharides that consists essentially of 6′-SL, LNnT and LSTc, made by treating 6′-SL and LNnT in the presence of an α2,6-transsialidase.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C07H 3/04 - Disaccharides
  • C07H 5/06 - Aminosugars
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • A61P 31/12 - Antivirals
  • A61P 31/04 - Antibacterial agents
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

88.

Separation of 2′-FL from a fermentation broth

      
Application Number 16895871
Grant Number 12060594
Status In Force
Filing Date 2020-06-08
First Publication Date 2020-09-24
Grant Date 2024-08-13
Owner Glycom A/S (Denmark)
Inventor
  • Dekany, Gyula
  • Osztrovszky, Györgyi
  • Matwiejuk, Martin
  • Chassagne, Pierre
  • Jondelius Hederos, Markus

Abstract

The invention relates to a method for selective crystallization of 2′-fucosyllactose (2′-FL) from an aqueous solution comprising 2′-FL and one or more other fucosylated carbohydrates by adding acetic acid to the solution. The aqueous solution is separated from an aqueous culture medium prior to crystallization.

IPC Classes  ?

  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
  • C07H 1/06 - SeparationPurification
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

89.

Mixtures of human milk oligosaccharides comprising 3′-O-sialyllactose

      
Application Number 16820126
Grant Number 11173171
Status In Force
Filing Date 2020-03-16
First Publication Date 2020-09-10
Grant Date 2021-11-16
Owner GLYCOM A/S (Denmark)
Inventor
  • Champion, Elise
  • Mcconnell, Bruce
  • Dekany, Gyula

Abstract

Barnesiella.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C12P 19/14 - Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase, e.g. by alpha-amylase
  • C12P 19/26 - Preparation of nitrogen-containing carbohydrates
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • C12P 19/00 - Preparation of compounds containing saccharide radicals
  • C07H 5/06 - Aminosugars
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
  • A61P 31/04 - Antibacterial agents
  • A61P 31/12 - Antivirals
  • A61K 31/7016 - Disaccharides, e.g. lactose, lactulose

90.

HUMAN MILK OLIGOSACCHARIDES FOR USE IN ENHANCING EXECUTIVE FUNCTION

      
Application Number IB2020051904
Publication Number 2020/178774
Status In Force
Filing Date 2020-03-05
Publication Date 2020-09-10
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine
  • Hauser, Jonas
  • Schneider, Nora

Abstract

Use of a human milk oligosaccharide (HMO), or a nutritional composition comprising a human milk oligosaccharide, to enhance executive function in a non-infant, to prevent and/or reduce the risk of sub- optimal executive function in a non-infant, to manage sub-optimal executive functioning in a non-infant, and/or to improve myelination to mature the pre -frontal cortex region of the brain in a non-infant, as well as synthetic compositions of HMOs and packs comprising at least 14 individual daily doses of an effective amount of at least one HMO for such a use.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

91.

AMORPHOUS SIALYLATED OLIGOSACCHARIDES

      
Application Number IB2020050332
Publication Number 2020/148693
Status In Force
Filing Date 2020-01-16
Publication Date 2020-07-23
Owner GLYCOM A/S (Denmark)
Inventor
  • Podányi, Benjámin
  • Matwiejuk, Martin
  • Molnár-Gábor, Dóra

Abstract

It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for improving the chemical stability and/or the physical features of an amorphous carbohydrate.

IPC Classes  ?

  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 3/44 - Freeze-drying
  • A23L 3/46 - Spray-drying

92.

Synthesis of oligosaccharides

      
Application Number 16626245
Grant Number 11214588
Status In Force
Filing Date 2018-06-27
First Publication Date 2020-07-09
Grant Date 2022-01-04
Owner GLYCOM A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Jondelius Hederos, Markus

Abstract

This invention relates to a method for the enzymatic synthesis of oligosaccharides, preferably human milk oligosaccharides (HMOs) The method comprises the enzymatic transfer of a glycosyl moiety and subsequent removal of by-products, such as lactose, by nanofiltration using a membrane comprising an active polyamide layer.

IPC Classes  ?

  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
  • C08B 37/00 - Preparation of polysaccharides not provided for in groups Derivatives thereof
  • B01D 61/02 - Reverse osmosisHyperfiltration
  • B01D 61/58 - Multistep processes
  • B01D 69/12 - Composite membranesUltra-thin membranes
  • C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
  • B01D 61/14 - UltrafiltrationMicrofiltration
  • C07H 1/06 - SeparationPurification
  • B01D 61/04 - Feed pretreatment
  • B01D 69/02 - Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or propertiesManufacturing processes specially adapted therefor characterised by their properties
  • B01D 71/56 - Polyamides, e.g. polyester-amides
  • B01D 71/58 - Other polymers having nitrogen in the main chain, with or without oxygen or carbon only
  • C12P 19/12 - Disaccharides

93.

Synthetic composition for reducing allergy symptoms

      
Application Number 16640956
Grant Number 11524019
Status In Force
Filing Date 2018-08-21
First Publication Date 2020-07-02
Grant Date 2022-12-13
Owner Glycom A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine

Abstract

This invention relates to a method and composition for inducing allergen tolerance in a patient suffering from an atopic allergy or allergic asthma; hence reducing allergy symptoms in these patients.

IPC Classes  ?

94.

SEPARATION OF OLIGOSACCHARIDES

      
Application Number IB2019061093
Publication Number 2020/128945
Status In Force
Filing Date 2019-12-19
Publication Date 2020-06-25
Owner GLYCOM A/S (Denmark)
Inventor
  • Khanzhin, Nikolay
  • Jondelius Hederos, Markus
  • Chassagne, Pierre

Abstract

The invention relates to a method for the separation of two hydrophilic neutral oligosaccharides from each other with a chromatography on a bromine functionalized polystyrene cross-linked with divinylbenzene (BPS-DVB) stationary medium.

IPC Classes  ?

  • B01D 15/08 - Selective adsorption, e.g. chromatography
  • C07H 1/06 - SeparationPurification
  • C12P 19/00 - Preparation of compounds containing saccharide radicals

95.

COMPOSITION AND METHOD FOR PROMOTING INTESTINAL BARRIER HEALING

      
Application Number IB2019061097
Publication Number 2020/128948
Status In Force
Filing Date 2019-12-19
Publication Date 2020-06-25
Owner GLYCOM A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce
  • Damak, Sami
  • Foata, Francis
  • Sprenger, Norbert

Abstract

A composition and associated packs and methods for (i) promoting gastrointestinal barrier healing in the upper intestinal tract and/or small intestine of a non-infant human suffering from chronic intestinal barrier inflammation, and/or (ii) maintaining remission in the upper intestinal tract and small intestine of a non-infant human suffering from chronic intestinal barrier inflammation. The composition contains an effective amount of a combination of 6'-sialyllactose (6'-SL) and lacto-N-tetraose (LNT).

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

96.

COMPOSITION AND METHOD FOR TREATING HUMANS USING LOW-FODMAP DIETS

      
Application Number IB2019061096
Publication Number 2020/128947
Status In Force
Filing Date 2019-12-19
Publication Date 2020-06-25
Owner GLYCOM A/S (Denmark)
Inventor
  • Mcconnell, Bruce
  • Vigsnæs, Louise Kristine

Abstract

A synthetic composition and method for use in providing a source of oligosaccharides to a human consuming a low-FODMAP diet, increasing the abundance of bifidobacteria in the colon of a human consuming a low-FODMAP diet, and/or reintroducing FODMAPs into the diet of a human consuming a low-FODMAP diet. The composition contains one or more human milk oligosaccharides.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A61K 35/745 - Bifidobacteria
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

97.

Miscellaneous Design

      
Application Number 1534633
Status Registered
Filing Date 2020-03-28
Registration Date 2020-03-28
Owner GLYCOM A/S (Denmark)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Chemicals for use in industry; biological preparations for use in industry and science; adjuvants, other than for medical or veterinary purposes; albumin [animal or vegetable, raw material]; antioxidants for use in the manufacture of pharmaceuticals; antioxidants for use in the manufacture of food supplements; biological preparations, other than for medical or veterinary purposes; casein for the food industry; chemical substances for preserving foodstuffs; cultures of microorganisms, other than for medical and veterinary use; enzyme preparations for the food industry; enzymes for the food industry; fatty acids; gelatine for industrial purposes; glucose for the food industry; gluten for the food industry; lactose for the food industry; lecithin for the food industry; milk ferments for the food industry; pectin for the food industry; proteins for use in manufacture; proteins for use in the manufacture of food supplements; proteins for the food industry; saccharin; sodium; starch for industrial purposes; vitamins for use in the manufacture of food supplements; vitamins for the food industry; vitamins for use in the manufacture of pharmaceuticals; human milk oligosaccharide (HMO) preparations for use in industry and as raw material, not for medical use; human milk oligosaccharide (HMO) additives for pharmaceuticals, nutraceuticals, infant formula, foodstuffs and animal foods; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for the food industry; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for scientific use (other than for medical or veterinary use); human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for industrial use; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for use in the manufacture of pharmaceuticals, nutraceuticals, infant formula, foodstuffs and animal foods; chemicals additives for use in the manufacture of dietary supplements and infant formula; industrial chemicals; oligosaccharides for use in foods; carbohydrates for use in food manufacture; proteins for use in food manufacture; oligosaccharides for use in the foods industry; carbohydrates for use in the foods industry; proteins for use in the foods industry. Dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; acai powder dietary supplements; adjuvants for medical purposes; albumin dietary supplements; albuminous foodstuffs for medical purposes; albuminous preparations for medical purposes; alginate dietary supplements; casein dietary supplements; dietary fibre; dietary supplements for animals; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances adapted for medical use; enzyme dietary supplements; glucose dietary supplements; homogenized food adapted for medical purposes; lacteal flour for babies; linseed dietary supplements; malted milk beverages for medical purposes; medicated animal feed; medicinal drinks; milk ferments for pharmaceutical purposes; lactose for pharmaceutical purposes; mineral food supplements; nutraceutical preparations for therapeutic or medical purposes, nutritional supplements; pollen dietary supplements; powdered milk for babies; protein dietary supplements; protein supplements for animals; royal jelly dietary supplements; starch for dietetic or pharmaceutical purposes, sugar for medical purposes; vitamin preparations; wheat germ dietary supplements; infant formula; medicated food additives for humans and for animals; preparations for use as additives for food for human or animal consumption (medicated), including vitamin preparations for use as a supplement for dietary supplements and infant formula; food supplements for dietetic use; dietary supplements for medical use; medicated supplements for foodstuffs for humans, including for infants, and for animals; mineral food supplements; colostrum supplements; dietary supplemental in the form of beverages; dietary supplements for infants; human milk oligosaccharide dietary supplements; human milk oligo-saccharide compounds for medical purposes; human milk oligosaccharide additives for use as supplements in connection with pharmaceuticals, nutraceuticals and infant formula; human milk oligosaccharide additives for use as a dietary or nutritional supplement; human milk oligosaccharide compounds and chemical and biological derivatives of human milk oligosaccharide compounds for medical use.

98.

SYNTHESIS OF THE FUCOSYLATED OLIGOSACCHARIDE LNFP-V

      
Application Number IB2019060423
Publication Number 2020/115671
Status In Force
Filing Date 2019-12-04
Publication Date 2020-06-11
Owner GLYCOM A/S (Denmark)
Inventor
  • Papadakis, Manos
  • Pedersen, Margit

Abstract

The present invention provides a method for biotechnological production of LNFP-V by using recombinant bacterial cells. LNFP-V is produced by using a polypeptide having an a1,3/4-fucosyl transferase activity and comprising or consisting of an amino acid sequence that has a sequence identity of at least 90 % with amino acid sequence of SEQ ID No. 1 or 3.

IPC Classes  ?

  • C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
  • C12N 1/21 - BacteriaCulture media therefor modified by introduction of foreign genetic material
  • C12N 9/10 - Transferases (2.)
  • C12R 1/19 - Escherichia coli

99.

Synthetic composition for microbiota modulation

      
Application Number 16613082
Grant Number 11291677
Status In Force
Filing Date 2018-05-09
First Publication Date 2020-05-28
Grant Date 2022-04-05
Owner Glycom A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

The invention relates to a composition comprising one or more human milk oligosaccharides (HMOs) for use in stimulating the production of butyrate in the gastro-intestinal tract of a non-infant human and obtaining delayed increase in the level of butyrate in the gastro-intestinal tract of the non-infant human, and methods for their use.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 35/745 - Bifidobacteria

100.

HMO compositions and methods for reducing detrimental proteolytic metabolites

      
Application Number 16616338
Grant Number 11541067
Status In Force
Filing Date 2018-05-24
First Publication Date 2020-05-21
Grant Date 2023-01-03
Owner Glycom A/S (Denmark)
Inventor
  • Vigsnæs, Louise Kristine
  • Mcconnell, Bruce

Abstract

A method and a composition comprising human milk oligosaccharides for decreasing the production of detrimental proteolytic metabolites such as ammonia and branched chain fatty acids in the intestinal microbiota of humans, which is useful for the treatment of brain-gut disorders like autism, stress, anxiety, and depressive disorders, are disclosed. Methods of treatment of colon cancer and liver damage are also disclosed.

IPC Classes  ?

  • A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
  1     2     3        Next Page